Kellerhals Carrard has announced the appointment of eight new partner and three new counsels. Meet the new partners Martin Föhse first joined Kellerhals Carrard in 2015. He specialises in constitutional and administrative law. He advises companies, federal, cantonal and municipal authorities as well as private individuals, also as an representative in court proceedings and in […]
Tags : Melanie Huber
Katadyn Group, a Swiss-based specialist in portable water filters and trekking food, has been acquired by a group of entrepreneurs led by Kontivia, a long-term, down-to-earth investment company and invests together with selected entrepreneurial families in established medium- sized companies in Switzerland and southern Germany. The acquisition was consummated through Bifolia Holding which was renamed in Katadyn Group following the closing of the transaction. The majority shareholder of Katadyn Holding, Adrian Schmassmann, and […]
Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At closing of the envisaged business combination, MoonLake will have access to approximately USD 230 million in cash (subject to redemptions), […]
Kellerhals Carrard has acted as legal counsel to Stille, a medical device company, in acquiring all shares in Switzerland-based S&T, a manufacturer of microsurgical instruments, in exchange for CHF 6 million paid in cash upon completion of the transaction and financed through Stille’s existing cash liquidity and bank loans. In addition to, CHF 2.5 million […]
MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany. MoonLake Immunotherapeutics was established by an international team of immunology specialists to create next-level therapies for inflammatory skin and joint […]
The team was led by partner Nicolas Mosimann (Corporate/M&A - pictured) and comprised associates Sophie Holdt, Sarah Schneider (both Corporate/M&A), Samuel Rickli (Notary), Melanie Huber and Larissa Simeon (both Employment).
